category
Nature Microbiology
date
Mar 16, 2026
slug
status
Published
summary
首次通过纵向宏转录组学揭示阿奇霉素在新冠肺炎患者中未表现出抗炎效果,反而导致潜在病原体富集和抗药基因增加,为抗生素临床应用提供新的微生物组学证据
tags
测序技术
type
Post

📄 原文题目

Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19

🔗 原文链接

💡 AI 核心解读

首次通过纵向宏转录组学揭示阿奇霉素在新冠肺炎患者中未表现出抗炎效果,反而导致潜在病原体富集和抗药基因增加,为抗生素临床应用提供新的微生物组学证据

📝 英文原版摘要

<p>Nature Microbiology, Published online: 16 March 2026; <a href="https://www.nature.com/articles/s41564-026-02285-8">doi:10.1038/s41564-026-02285-8</a></p>Longitudinal metatranscriptomics in a prospective cohort of 1,164 adults hospitalized for COVID-19 reveals that azithromycin offered no apparent anti-inflammatory benefit but enriched the respiratory microbiome with potential pathogens and antimicrobial resistance genes.
RNA的系统级测量、建模与操控早产儿来源的梭菌属代谢人乳低聚糖以抑制致病共生菌并调节类器官肠道功能
Loading...